Working During Cancer Treatment: Your FMLA and ADA Rights
Working During Cancer Treatment: Your FMLA and ADA Rights Cure Today
Онкология
🎗️Лента новостей
Онкология
Adding abiraterone to ADT and docetaxel improves survival in metastatic prostate cancer
Adding abiraterone to standard treatment provides a lasting survival benefit for men whose prostate cancer has already spread at diagnosis, reinforcing the value of early treatment intensification. The findings come from almost eight years of follow-up in the academically led phase 3 PEACE-1 trial presented at the…
Онкология
Обнаружен эффективный способ борьбы с распространенным видом рака кишечника
Обнаружен эффективный способ борьбы с распространенным видом рака кишечника Lenta News
Онкология
Обнаружен эффективный способ борьбы с распространенным видом рака кишечника
Обнаружен эффективный способ борьбы с распространенным видом рака кишечника Lenta News
Онкология
ESMO 2026: Key Findings for Cancer Care and Drug Development, Upcoming Webinar Hosted by Xtalks
ESMO 2026: Key Findings for Cancer Care and Drug Development, Upcoming Webinar Hosted by Xtalks PR Newswire
🎗️
Онкология
How Melanoma Became the Proving Ground for a Personalized Cancer Vaccine
How Melanoma Became the Proving Ground for a Personalized Cancer Vaccine Bloomberg.com
Онкология
New treatment approach shows promise in reducing prostate cancer spread
New treatment approach shows promise in reducing prostate cancer spread McGill University
Онкология
Omega-3 EPA linked to longer survival after surgery for colorectal cancer liver metastases
Patients assigned to receive high-dose eicosapentaenoic acid (EPA), an omega-3 fatty acid, before and after surgery for colorectal cancer liver metastases had longer overall survival than those assigned to receive placebo, according to results of the phase 3 EMT2 trial presented at the ESMO Congress 2026, held in…
Онкология
В Челнах проверяют жалобу на врачей после смерти пенсионера от рака
В Челнах проверяют жалобу на врачей после смерти пенсионера от рака Newsroom24
Онкология
Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market
Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market The Manila Times
Онкология
Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market
Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market The Manila Times
Онкология
Тарлатамаб с дурвалумабом продлил жизнь при мелкоклеточном раке легкого
Тарлатамаб с дурвалумабом продлил жизнь при мелкоклеточном раке легкого the Pharma Media
🎗️
Онкология
Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market
Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market WBOC TV
🎗️
Онкология
Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market
Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market GlobeNewswire
Онкология
Найдено средство для снижения риска рецидива рака на 42 процента
Найдено средство для снижения риска рецидива рака на 42 процента Lenta News